Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lapi

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|December 19, 2024
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacyJohn K Cini, Richard T Kenney, Susan Dexter, et al.
Surgery|October 21, 2019
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentRachael Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Analytical Chemistry|September 26, 2015
Harvesting (67)Cu from the Collection of a Secondary Beam Cocktail at the National Superconducting Cyclotron LaboratoryTara Mastren, Aranh Pen, Shaun Loveless, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2019
Imaging of HER2 with [<sup>89</sup>Zr]pertuzumab in Response to T-DM1 TherapyAdriana V F Massicano, Supum Lee, Bryant K Crenshaw, et al.
Surgery|April 20, 2021
Corrigendum to: Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment [Surgery. 2020 Jan;167(1):189-196. doi: 10.1016/j.surg.2019.05.092. Epub 2019 Oct 16.PMID: 31629542]R Guenter, T Aweda, D M Carmona Matos, et al.
JCI Insight|March 17, 2023
Impaired PPARγ activation by cadmium exacerbates infection-induced lung injuryJennifer L Larson-Casey, Shanrun Liu, Jennifer M Pyles, et al.
Dalton Transactions (Cambridge, England : 2003)|July 11, 2013
Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditionsJames C Knight, Melinda Wuest, Fawaz A Saad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Nuclear Medicine and Biology|February 22, 2023
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetryWilson Lin, Eduardo Aluicio-Sarduy, Hailey A Houson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 16, 2020
Production of [<sup>89</sup> Zr]Oxinate<sub>4</sub> and cell radiolabeling for human useAdriana V F Massicano, Jennifer L Bartels, Charlotte D Jeffers, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|December 19, 2024
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacyJohn K Cini, Richard T Kenney, Susan Dexter, et al.
Surgery|October 21, 2019
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentRachael Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Analytical Chemistry|September 26, 2015
Harvesting (67)Cu from the Collection of a Secondary Beam Cocktail at the National Superconducting Cyclotron LaboratoryTara Mastren, Aranh Pen, Shaun Loveless, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2019
Imaging of HER2 with [<sup>89</sup>Zr]pertuzumab in Response to T-DM1 TherapyAdriana V F Massicano, Supum Lee, Bryant K Crenshaw, et al.
Surgery|April 20, 2021
Corrigendum to: Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment [Surgery. 2020 Jan;167(1):189-196. doi: 10.1016/j.surg.2019.05.092. Epub 2019 Oct 16.PMID: 31629542]R Guenter, T Aweda, D M Carmona Matos, et al.
JCI Insight|March 17, 2023
Impaired PPARγ activation by cadmium exacerbates infection-induced lung injuryJennifer L Larson-Casey, Shanrun Liu, Jennifer M Pyles, et al.
Dalton Transactions (Cambridge, England : 2003)|July 11, 2013
Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditionsJames C Knight, Melinda Wuest, Fawaz A Saad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancerSuzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Nuclear Medicine and Biology|February 22, 2023
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetryWilson Lin, Eduardo Aluicio-Sarduy, Hailey A Houson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 16, 2020
Production of [<sup>89</sup> Zr]Oxinate<sub>4</sub> and cell radiolabeling for human useAdriana V F Massicano, Jennifer L Bartels, Charlotte D Jeffers, et al.
Pageof 20